GRI Bio (GRI) Cash from Investing Activities (2020 - 2023)
GRI Bio (GRI) posted quarterly Cash from Investing Activities of -$8000.0 for Q2 2023, up 99.31% year-over-year from -$4013.9 in Q2 2022, and down 166.67% quarter-over-quarter from -$3000.0 in Q4 2022.
GRI Bio (GRI) Cash from Investing Activities (2020 - 2023) Analysis & Trends
GRI Bio's Cash from Investing Activities history runs 4 years deep, the most recent figure standing at -$8000.0 for Q2 2023.
- In Q2 2023, Cash from Investing Activities rose 99.31% year-over-year to -$8000.0; the TTM figure through Sep 2024 stood at -$8000.0 (up 27.27% YoY), while the FY2025 annual figure was -$3000.0, changed N/A from the prior year.
- Cash from Investing Activities for Q2 2023 stood at -$8000.0, down from -$3000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $1.2 million in Q1 2022, with the low at -$3.3 million in Q3 2021.
- The 4-year median for Cash from Investing Activities is -$8000.0 (2023), against an average of -$550714.3.
- The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities surged 99.48% in 2022, then surged 99.31% in 2023.
- GRI Bio's Cash from Investing Activities stood at -$2000.0 in 2020, then sank by 28700.0% to -$576000.0 in 2021, then soared by 99.48% to -$3000.0 in 2022, then plunged by 166.67% to -$8000.0 in 2023.
- Business Quant data shows GRI's Cash from Investing Activities at -$8000.0 in Q2 2023, -$3000.0 in Q4 2022, and -$1.2 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | GRI Bio | 3.01 Mn | 3.01 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -8,000.00 |
| Jun 30, 2023 | -8,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Jun 30, 2022 | -1.15 Mn |
| Jun 30, 2022 | -1.15 Mn |
| Mar 31, 2022 | 1.15 Mn |
| Mar 31, 2022 | 1.15 Mn |
| Dec 31, 2021 | -576,000.00 |
| Dec 31, 2021 | -576,000.00 |
| Sep 30, 2021 | -3.27 Mn |
| Sep 30, 2021 | -3.27 Mn |
| Mar 31, 2020 | -2,000.00 |
| Mar 31, 2020 | -2,000.00 |